Cosponsor
Sign in

HJRES 34 · in committee · significant

Providing for congressional disapproval under chapter 8 of title 5, United States Code, of the rule submitted by the Environmental Protection Agency relating to "Trichloroethylene (TCE); Regulation Under the Toxic Substances Control Act (TSCA)".

Show full title

Providing for congressional disapproval under chapter 8 of title 5, United States Code, of the rule submitted by the Environmental Protection Agency relating to "Trichloroethylene (TCE); Regulation Under the Toxic Substances Control Act (TSCA)".

What this bill does

  • This resolution blocks an EPA rule that prohibits manufacturing, importing, and using trichloroethylene (TCE) in all applications.
  • The rule affects manufacturers, importers, and businesses that use TCE in industrial and commercial operations.
  • The nullification takes effect under congressional disapproval procedures established in federal administrative law.

Generated by claude-haiku-4-5

Community Threads

Started by Cosponsor

  1. 01

    What evidence exists that the EPA's TCE ban would significantly harm specific industries or communities compared to the health risks the regulation aims to address?

  2. 02

    How would blocking this rule affect workers and residents currently exposed to TCE in manufacturing facilities and contaminated areas?

  3. 03

    Which businesses depend on TCE use, and what alternative chemicals or processes are available to replace it if the ban proceeds?

Cosponsor writes these to seed civic discussion — they aren't user posts. Sign in to reply.

Sponsor · R-TN-1

Diana Harshbarger

Citizen cosponsors

0

In Congress

1/ 435

House Reps cosponsoring

Introduced 2025-02-04

Joining the bill

Legislative timeline

  1. 2025-02-04 · house · IntroReferral

    Referred to the House Committee on Energy and Commerce.

  2. 2025-02-04 · IntroReferral

    Introduced in House

  3. 2025-02-04 · IntroReferral

    Introduced in House

Congress.gov ↗

Citizen comments

Sign in to comment on this bill.

No comments yet — be the first.